Skip To Content

ACD/Labs Blog

The pharmaceutical industry has renewed its interest in HTE these last few years. Leaders see it as a way to get medicines to patients faster, but they’re also attracted by the sheer quantity of data generated in parallel experiments. How and where should HTE be set up for maximum success? Read this blog for questions that should be considered.

For scientists involved in pharmaceutical development, high throughput experimentation is commonplace. While there are many observed benefits with HTE workflows, there are also significant impediments to its utilization. The industry requires a technological solution that can help streamline workflows and demonstrate data integrity. That's why we've recently launched Katalyst D2D.